Biblio

Export 22 results:
Author Title [ Type(Desc)] Year
Filters: Author is Rowe, Christopher C  [Clear All Filters]
Journal Article
M. T. Fodero-Tavoletti, Okamura, N., Furumoto, S., Mulligan, R. S., Connor, A. R., McLean, C. A., Cao, D., Rigopoulos, A., Cartwright, G. A., O'Keefe, G., Gong, S., Adlard, P. A., Barnham, K. J., Rowe, C. C., Masters, C. L., Kudo, Y., Cappai, R., Yanai, K., and Villemagne, V. L., 18F-THK523: a novel in vivo tau imaging ligand for Alzheimer's disease., Brain, vol. 134, no. Pt 4, pp. 1089-100, 2011.
R. N. Martins, Villemagne, V., Sohrabi, H. R., Chatterjee, P., Shah, T. M., Verdile, G., Fraser, P., Taddei, K., Gupta, V. B., Rainey-Smith, S. R., Hone, E., Pedrini, S., Lim, W. Ling, Martins, I., Frost, S., Gupta, S., O'Bryant, S., Rembach, A., Ames, D., Ellis, K., Fuller, S. J., Brown, B., Gardener, S. L., Fernando, B., Bharadwaj, P., Burnham, S., Laws, S. M., Barron, A. M., Goozee, K., Wahjoepramono, E. J., Asih, P. R., Doecke, J. D., Salvado, O., Bush, A. I., Rowe, C. C., Gandy, S. E., and Masters, C. L., Alzheimer's Disease: A Journey from Amyloid Peptides and Oxidative Stress, to Biomarker Technologies and Disease Prevention Strategies-Gains from AIBL and DIAN Cohort Studies., J Alzheimers Dis, vol. 62, no. 3, pp. 965-992, 2018.
Q. - X. Li, Villemagne, V. L., Doecke, J. D., Rembach, A., Sarros, S., Varghese, S., McGlade, A., Laughton, K. M., Pertile, K. K., Fowler, C. J., Rumble, R. L., Trounson, B. O., Taddei, K., Rainey-Smith, S. R., Laws, S. M., Robertson, J. S., Evered, L. A., Silbert, B., Ellis, K. A., Rowe, C. C., S Macaulay, L., Darby, D., Martins, R. N., Ames, D., Masters, C. L., and Collins, S., Alzheimer's Disease Normative Cerebrospinal Fluid Biomarkers Validated in PET Amyloid-β Characterized Subjects from the Australian Imaging, Biomarkers and Lifestyle (AIBL) study., J Alzheimers Dis, vol. 48, no. 1, pp. 175-87, 2015.
S. Hollands, Lim, Y. Ying, Laws, S. M., Villemagne, V. L., Pietrzak, R. H., Harrington, K., Porter, T., Snyder, P., Ames, D., Fowler, C., Rainey-Smith, S. R., Martins, R. N., Salvado, O., Robertson, J., Rowe, C. C., Masters, C. L., and Maruff, P., APOEɛ4 Genotype, Amyloid, and Clinical Disease Progression in Cognitively Normal Older Adults., J Alzheimers Dis, vol. 57, no. 2, 2017.
W. M. A. D. Bino Fernando, Rainey-Smith, S. R., Gardener, S. L., Villemagne, V. L., Burnham, S. C., S Macaulay, L., Brown, B. M., Gupta, V. Bala, Sohrabi, H. R., Weinborn, M., Taddei, K., Laws, S. M., Goozee, K., Ames, D., Fowler, C., Maruff, P., Masters, C. L., Salvado, O., Rowe, C. C., and Martins, R. N., Associations of Dietary Protein and Fiber Intake with Brain and Blood Amyloid-β., J Alzheimers Dis, vol. 61, no. 4, pp. 1589-1598, 2018.
W. R. Leifert, Nguyen, T., Rembach, A., Martins, R., Rainey-Smith, S., Masters, C. L., Ames, D., Rowe, C. C., S Macaulay, L., François, M., and Fenech, M. F., Buccal Cell Cytokeratin 14 Correlates with Multiple Blood Biomarkers of Alzheimer's Disease Risk., J Alzheimers Dis, vol. 48, no. 2, pp. 443-52, 2015.
Y. Xia, Yassi, N., Raniga, P., Bourgeat, P., Desmond, P., Doecke, J., Ames, D., Laws, S. M., Fowler, C., Rainey-Smith, S. R., Martins, R., Maruff, P., Villemagne, V. L., Masters, C. L., Rowe, C. C., Fripp, J., and Salvado, O., Comorbidity of Cerebrovascular and Alzheimer's Disease in Aging., J Alzheimers Dis, vol. 78, no. 1, pp. 321-334, 2020.
Y. Ying Lim, Williamson, R., Laws, S. M., Villemagne, V. L., Bourgeat, P., Fowler, C., Rainey-Smith, S., Salvado, O., Martins, R. N., Rowe, C. C., Masters, C. L., and Maruff, P., Effect of APOE Genotype on Amyloid Deposition, Brain Volume, and Memory in Cognitively Normal Older Individuals., J Alzheimers Dis, vol. 58, no. 4, pp. 1293-1302, 2017.
J. E. Baker, Lim, Y. Ying, Jaeger, J., Ames, D., Lautenschlager, N. T., Robertson, J., Pietrzak, R. H., Snyder, P. J., Villemagne, V. L., Rowe, C. C., Masters, C. L., and Maruff, P., Episodic Memory and Learning Dysfunction Over an 18-Month Period in Preclinical and Prodromal Alzheimer's Disease., J Alzheimers Dis, vol. 65, no. 3, pp. 977-988, 2018.
M. N. Sabbagh, Schäuble, B., Anand, K., Richards, D., Murayama, S., Akatsu, H., Takao, M., Rowe, C. C., Masters, C. L., Barthel, H., Gertz, H. - J., Peters, O., Rasgon, N., Jovalekic, A., Sabri, O., Schulz-Schaeffer, W. J., and Seibyl, J., Histopathology and Florbetaben PET in Patients Incorrectly Diagnosed with Alzheimer's Disease., J Alzheimers Dis, vol. 56, no. 2, pp. 441-446, 2017.
S. L. Gardener, Rainey-Smith, S. R., Sohrabi, H. R., Weinborn, M., Verdile, G., Fernando, W. M. A. D. Bino, Lim, Y. Ying, Harrington, K., Burnham, S., Taddei, K., Masters, C. L., Macaulay, S. L., Rowe, C. C., Ames, D., Maruff, P., and Martins, R. N., Increased Carbohydrate Intake is Associated with Poorer Performance in Verbal Memory and Attention in an APOE Genotype-Dependent Manner., J Alzheimers Dis, vol. 58, no. 1, pp. 193-201, 2017.
S. L. Gardener, Weinborn, M., Sohrabi, H. R., Doecke, J. D., Bourgeat, P., Rainey-Smith, S. R., Shen, K. - K., Fripp, J., Taddei, K., Maruff, P., Salvado, O., Savage, G., Ames, D., Masters, C. L., Rowe, C. C., and Martins, R. N., Longitudinal Trajectories in Cortical Thickness and Volume Atrophy: Superior Cognitive Performance Does Not Protect Against Brain Atrophy in Older Adults., J Alzheimers Dis, vol. 81, no. 3, pp. 1039-1052, 2021.
S. Ramanan, Flanagan, E., Leyton, C. E., Villemagne, V. L., Rowe, C. C., Hodges, J. R., and Hornberger, M., Non-Verbal Episodic Memory Deficits in Primary Progressive Aphasias are Highly Predictive of Underlying Amyloid Pathology., J Alzheimers Dis, vol. 51, no. 2, pp. 367-76, 2016.
P. Chatterjee, Doré, V., Pedrini, S., Krishnadas, N., Thota, R., Bourgeat, P., Ikonomovic, M. D., Rainey-Smith, S. R., Burnham, S. C., Fowler, C., Taddei, K., Mulligan, R., Ames, D., Masters, C. L., Fripp, J., Rowe, C. C., Martins, R. N., and Villemagne, V. L., Plasma Glial Fibrillary Acidic Protein Is Associated with 18F-SMBT-1 PET: Two Putative Astrocyte Reactivity Biomarkers for Alzheimer's Disease., J Alzheimers Dis, vol. 92, no. 2, pp. 615-628, 2023.
S. Pedrini, Hone, E., Gupta, V. B., James, I., Teimouri, E., Bush, A. I., Rowe, C. C., Villemagne, V. L., Ames, D., Masters, C. L., Rainey-Smith, S., Verdile, G., Sohrabi, H. R., Raida, M. R., Wenk, M. R., Taddei, K., Chatterjee, P., Martins, I., Laws, S. M., and Martins, R. N., Plasma High Density Lipoprotein Small Subclass is Reduced in Alzheimer's Disease Patients and Correlates with Cognitive Performance., J Alzheimers Dis, vol. 77, no. 2, pp. 733-744, 2020.
C. Dang, Harrington, K. D., Lim, Y. Ying, Ames, D., Hassenstab, J., Laws, S. M., Yassi, N., Hickey, M., Rainey-Smith, S., Robertson, J., Sohrabi, H. R., Salvado, O., Weinborn, M., Villemagne, V. L., Rowe, C. C., Masters, C. L., and Maruff, P., Relationship Between Amyloid-β Positivity and Progression to Mild Cognitive Impairment or Dementia over 8 Years in Cognitively Normal Older Adults., J Alzheimers Dis, vol. 65, no. 4, pp. 1313-1325, 2018.
A. Elias, Cummins, T., Tyrrell, R., Lamb, F., Doré, V., Williams, R., Rosenfeld, J. V., Hopwood, M., Villemagne, V. L., and Rowe, C. C., Risk of Alzheimer's Disease in Obstructive Sleep Apnea Syndrome: Amyloid-β and Tau Imaging., J Alzheimers Dis, vol. 66, no. 2, pp. 733-741, 2018.
B. M. Brown, Rainey-Smith, S. R., Doré, V., Peiffer, J. J., Burnham, S. C., Laws, S. M., Taddei, K., Ames, D., Masters, C. L., Rowe, C. C., Martins, R. N., and Villemagne, V. L., Self-Reported Physical Activity is Associated with Tau Burden Measured by Positron Emission Tomography., J Alzheimers Dis, vol. 63, no. 4, pp. 1299-1305, 2018.
M. D. Zwan, Villemagne, V. L., Doré, V., Buckley, R., Bourgeat, P., Veljanoski, R., Salvado, O., Williams, R., Margison, L., Rembach, A., S Macaulay, L., Martins, R., Ames, D., van der Flier, W. M., Ellis, K. A., Scheltens, P., Masters, C. L., and Rowe, C. C., Subjective Memory Complaints in APOEɛ4 Carriers are Associated with High Amyloid-β Burden., J Alzheimers Dis, vol. 49, no. 4, pp. 1115-22, 2016.
R. A. Sperling, Aisen, P. S., Beckett, L. A., Bennett, D. A., Craft, S., Fagan, A. M., Iwatsubo, T., Jack, C. R., Kaye, J., Montine, T. J., Park, D. C., Reiman, E. M., Rowe, C. C., Siemers, E., Stern, Y., Yaffe, K., Carrillo, M. C., Thies, B., Morrison-Bogorad, M., Wagster, M. V., and Phelps, C. H., Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease., Alzheimers Dement, vol. 7, no. 3, pp. 280-92, 2011.
T. Porter, Burnham, S. C., Milicic, L., Savage, G., Maruff, P., Lim, Y. Ying, Li, Q. - X., Ames, D., Masters, C. L., Rainey-Smith, S., Rowe, C. C., Salvado, O., Groth, D., Verdile, G., Villemagne, V. L., and Laws, S. M., Utility of an Alzheimer's Disease Risk-Weighted Polygenic Risk Score for Predicting Rates of Cognitive Decline in Preclinical Alzheimer's Disease: A Prospective Longitudinal Study., J Alzheimers Dis, vol. 66, no. 3, pp. 1193-1211, 2018.
N. Krishnadas, Huang, K., Schultz, S. A., Doré, V., Bourgeat, P., M Y Goh, A., Lamb, F., Bozinovski, S., Burnham, S. C., Robertson, J. S., Laws, S. M., Maruff, P., Masters, C. L., Villemagne, V. L., and Rowe, C. C., Visually Identified Tau 18F-MK6240 PET Patterns in Symptomatic Alzheimer's Disease., J Alzheimers Dis, vol. 88, no. 4, pp. 1627-1637, 2022.